Referent:innen

Dr. Sue Mann

Dr. Sue Mann

Sue Mann Consultancy

Dr Susanne Ding

Dr Susanne Ding

Boehringer Ingelheim Pharma

Dr. Julia Gudd

Dr. Julia Gudd

Behörde für Justiz und Verbraucherschutz (BJV)

Patryk Jegorow

Patryk Jegorow

Takeda

Dr Ulrich Kissel

Dr Ulrich Kissel

European QP Association (EQPA), KisselPharmaConsulting

Savvas Koulouridas

Savvas Koulouridas

Fagron BV

Aidan Madden

Aidan Madden

FivePharma

Dr Lance Smallshaw

Dr Lance Smallshaw

UCB Pharma

Zielsetzung

IMP Pre-Course Session
This pre-course session provides a detailed overview of the basic and specific characteristics in IMP manufacturing a QP must know to certify IMP batches for the release for clinical trials.
 
Qualified Person Education Course
Broaden and intensify your knowledge of the Qualified Person’s duties and responsibilities. Experts from the EQPA Board of Directors, pharmaceutical industry and regulatory authority will share their experience on important issues of the QP’s daily business and will give first-hand information on current and future expectations.

Hintergrund

IMP Pre-Course Session
The manufacture of investigational medicinal products (IMPs), including labelling, packaging, testing and certification, is carried out in accordance with the applicable GMP regulations. However, this is not a routine process, since, among other things, manufacturing and packaging procedures might be different for each and every clinical trial. The Qualified Person (QP) must therefore consider these particularities and the GMP/GCP Interface.
 
Qualified Person Education Course
Over the last years the role and responsibilities of the Qualified Persons have been increasing considerably. As a key person in the company, the QP has to consider many issues and has to take up the challenges within its areas of responsibilities. Additionally, as laid out in Article 49 of the European Directive 2001/83/EC, the QP needs to be highly qualified and experienced. This education course is one important part to help the QP be on top of current developments in GMP and regulatory requirements.

Zielgruppe

IMP Pre-Course Session
New colleagues becoming IMP QPs, QPs looking for continuous training and personnel of CROs and “non-commercial” IMP organisations.
 
Qualified Person Education Course
New and future Qualified Persons, QPs who are looking for ongoing training and personnel who want to get a detailed overview of the role and responsibilities of a  QP.

Date & Venue

Date Pre-course Session: IMP QP Education Course
Tuesday, 25 March 2025, 9.00 – 17.45 h
(Registration and coffee 8.30 – 9.00 h)

Date QP Education Course – Module A
Wednesday, 26 March 2025, 9.00 – 18.00h
(Registration and coffee 8.30 – 9.00)
Thursday, 27 March 2025, 8.30 – 15.30 h

Venue for both events
Doubletree by Hilton Vienna Schönbrunn
Schlossallee 8
1140 Vienna
Austria
Tel.: +43/ 1/ 89 110
E-Mail: info@doubletree-schonbrunn.at

Programm

Qualified Person Education Course Module A PLUS IMP Pre-Course Session

Gesamtes Programm als PDF herunterladen

Programme Pre-Course Session: Investigational Medicinal Products (IMP) QP Education Course

Principles of Clinical Trials

  •  Introduction to Clinical Trials
  •  Principles involved in;
      - API and excipients
      - Bulk manufacturing
      - Packing and labelling
      - QP Certification and batch release
  • Final Thoughts for the QP
Specific Legal Requirements for IMPs
  •  Definitions
  •  Clinical Trial Regulation 536/2014
  •  Clinical Trial Directive 2001/20/EC 
  •  MD Regulation 2017/745
  •  IMP Guidelines (various) 
  •  Content of phase appropriate QMS overview
GMP meets Clinical Trials – Differences between IMPs and Commercial Products
  •  Starting materials – Active pharmaceutical ingredient, excipient, diluent / reconstitution media
  •  Bulk
  •  Placebo
  •  Comparator
  •  Auxiliary Medicinal Product AxMP 
  •  Trial design, randomization
  •  Order
  •  Blinding principles
  •  Packaging Scenarios
  •  Labelling
  •  Exemptions from the manufacturing authorization for packaging & labelling
  •  Future concepts

IMP Batch Confirmation, QP Certification and IMP Release

  • Definitions / Regulations / Guidelines
  • IMP Release Process
  • Distribution Concept / Controlled Shipment of IMPs
GMP/ GDP/ GCP Interface
  • Reconstitution
  • Pre-requisites for randomisation and blinding 
  • Distribution
  • Stability and shelf-life extensions
  • Trial Master File
  • Site to site Transfers
  • Complaints and recall
  • End of study
  • Where does QP responsibility end?
 
Programme QP Education Course Module A
 
The Legal and Professional Duties of the Qualified Person
  • The EU legislation and regulation Framework
  • Requirements for becoming a QP
  • Role and duties of a QP
Update on European Requirements
  • EU GMP Guide Chapters
  • EU GMP Guide Annexes
  • Other important News
  • What the QP needs to be aware of
Delegation of Duties and Responsibilities
  • Duties and responsibilities of a QP (summary)
  • Delegation of duties and responsibilities
       - Annex 16
       - Importation
       - Assessments by others
  • Summary
Workshop on Case Studies: QP Discretion and Batch Certification
  • Batch certification: degrees of freedom and limits
  • Batch deviations and QP Certification: To certify or not, that’s the question
What the QP needs to know about Pharmacopoeias
  • The world of different Pharmacopoeias
  • Pharmacopoeias are more than just Monographs
  • How to deal with different methods
The role of QC and QA in Release (Presentation and Workshop)
  • Involvement of the QP
  • Role and responsibility of the Head of Quality Control
  • Responsibility of the QP
What the QP needs to know regarding the Supply Chain (from Supplier Qualification to GDP)
  • Introduction to Supply Chains and expectations
  • QP´s role in supplier qualification and auditing
  • Written confirmation and QP Declaration
  • GMP meets GDP: where does the responsibility end?
  • QP’s involvement in the recall process
  • QP’s role in drug shortages
How the QP fits into the Quality Systems
  • How much involvement is needed in systems like:
      - Product Quality Review
      - Inspection Management
      - Batch Record Review
      - CAPA
      - Change Control
      - Validation
      - Complaints and recalls
Liability and Indemnification
  • Liability and indemnification of QPs
  • Responsibility in the pharmaceutical Industry
  • Types of drug-related product liability Claims
  • Advanced tips -trends in liability
  • Examples (interactive part)
Workshop: Deviations during the Manufacture of an API – What Actions should you take as the responsible QP?

ECA-Member*: € 2190,-
Non ECA Member*: € 2490,-
EU/GMP Inspectorates*: € 1245,-
QP Member Discount*: € 2190,-

Alle Preise zzgl. MwSt. Wichtige Hinweise zur Umsatzsteuer.

* auch unkompliziert per Kreditkarte bezahlbar
American Express Visa Mastercard

icon
Weitere Termine vor Ort
Weitere Termine vor Ort nicht verfügbar
icon
Weitere Termine online
Weitere Termine online nicht verfügbar
icon
Aufzeichnung nicht verfügbar

Zurück

Teilnehmerstimmen - das sagen andere über unsere Seminare:

"Die Umsetzung mit Memberspot ist wirklich ausgezeichnet gelungen.
Es unterstützt die Wissensvermittlung und gewährleistet auch die richtige Durchführung des Kurses.”
Christian Wagener, WAGENER & CO. GmbH
GMP Basis-Einstiegsschulung (B 1) - Aufzeichnung Online Seminar, April 2024

„Kurzweilig, informativ“
Behrendt, Christian, IOI Oleo GmbH


„Austausch zwischen Teilnehmern & Vortragenden sorgt für Anstöße & Optimierungsmöglichkeiten im eigenen Unternehmen! Praxisnahe Beispiele veranschaulichen und vertiefen die Theorie sehr gut“
Marina Maier, CHEPLAPHARM Arzneimittel GmbH

Abweichungen und CAPA (QS 12)
November 2024

„Danke für das tolle und interessante Seminar! Ich nehme mir fachlich total viel mit und habe viele tolle Menschen kennengelernt.“
Melanie Schifferer, DAIICHI SANKYO EUROPE GmbH
Batch Record Review (QS 23)
September 2024

Guter, breit gefächerter Überblick mit interessanten Verknüpfungen zur Praxis,
welche die Theorie super veranschaulicht.”
Marina Kicoranovic, Labor Hartmann GmbH
GMP/Basis-Einstiegsschulung (B 14), September 2023

Die Referenten waren sehr gut! Sie haben sehr klar gesprochen, nur sehr wenige englische Begriffe
verwendet (super) und waren sehr praxisbezogen.”
Astrid Gießler, Regierungspräsidium Karlsruhe
Live Online Seminar - Basiskurs Computervalidierung & Datenintegrität im GxP Umfeld (B 3), Juni 2023

Sehr guter Bezug zur Schulung für einen GMP-Anfänger. Habe mich sehr gut abgeholt gefühlt.”
Dr. Harald Werner, Infraserv GmbH & Co. Höchst KG
GMP-Basisschulung (B 1), Juni 2023

„Interessante Themen, gut vorgetragen, die eigenen Erfahrungen der Vortragenden helfen, dies noch besser nachzuvollziehen.“ „Gute Gestaltung der Workshops, das Zusammenarbeiten in Gruppen und der Austausch mit anderen hilft sehr.“
Manuela Seibert, Merck, GMP-Leadauditor/in (FA 2), April 2024

NEWSLETTER

Bleiben Sie informiert mit dem GMP Newsletter von Concept Heidelberg!

GMP Newsletter

Concept Heidelberg bietet verschieden GMP Newsletter die Sie auf Ihren Bedarf hin zusammenstellen können.

Hier können Sie sich kostenfrei registrieren.

Kontakt

Kontaktieren Sie uns

Haben Sie Fragen?

Concept Heidelberg GmbH
Rischerstraße 8
69123 Heidelberg

Tel. :+49622184440
Fax : +49 6221 84 44 84
E-Mail: info@concept-heidelberg.de

zum Kontaktformular